Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells

Clinical Immunology

Volumn 128, Issue 2, 2008, Pages 181-189

  Suhoski, M M ^a   Perez, E E ^b   Heltzer, M L ^b   Laney, A ^b   Shaffer, L G ^c   Saitta, S ^b   Nachman, S ^d   Spinner, N B ^b   June, C H ^a   Orange, J S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c PerkinElmer   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1p36; 4 1BB; OX40; Primary immunodeficiency; Subtelomeric deletion; T cell memory; TNFRSF superfamily

Indexed keywords

CD134 ANTIGEN;

ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY T LYMPHOCYTE; MONOSOMY; MONOSOMY 1P36; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPTICEMIA;

CD4-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENE DELETION; HUMANS; LYMPHOCYTE ACTIVATION; MONOSOMY; RECEPTORS, OX40;

EID: 46749085819     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.03.522     Document Type: Article

References (42)

1. Heilstedt H.A., Ballif B.C., Howard L.A., Lewis R.A., Stal S., Kashork C.D., Bacino C.A., Shapira S.K., and Shaffer L.G. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am. J. Hum. Genet. 72 (2003) 1200-1212
2. Shapria S.K., McCaskill C., Northrup H., Spikes A.S., Elder F.F.B., Sutton V.R., Korenberg J.R., Greenberg F., and Shaffer L.G. Chromosome 1p36 deletions: The clinical phenotype and molecular characterization of a common newly delineated syndrome. Am. J. Hum. Genet. 61 (1997) 642-650
3. Kurosawa K., Kawame H., Okamoto N., Ochiai Y., Akatsuka A., Kobayashi M., Shimohira M., Mizuno S., Wada K., Fukushima Y., Kawawaki H., Yamamoto T., Masuno M., Imaizumi K., and Kuroki Y. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrom. Brain Dev. 27 (2005) 378-382
4. Gajecka M., Yu W., Ballif B.C., Glotzbach C.D., Bailey K.A., Shaw C.A., Kashork C.D., Heilstedt H.A., Ansel D.A., Theisen A., Rice R., Rice D.P.C., and Shaffer L.G. Delineation of mechanisms and regions of dosage imbalance in complex rearrangements of 1p36 leads to a putative gene for regulation of cranial suture closure. Eur. J. Hum. Genet. 13 (2005) 139-149
5. Neumann L.M., Polster T., Spantzel T., and Bartsch O. Unexpected death of a 12 year old boy with monosomy 1p36. Genet. Couns. 15 (2004) 19-26
6. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat. Rev., Immunol. 3 (2003) 609-620
7. Watts T.H. Tnf/tnfr family members in costimulation of T cell responses. Annu. Rev. Immunol. 23 (2005) 23-68
8. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14 (2003) 265-273
9. Weinberg A.D., Evans D.E., Thalhofer C., Shi T., and Prell R.A. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement. J. Leukoc. Biol. 75 (2004) 962-972
10. Song A.H., Tang X.H., Harms K.M., and Croft M. OX40 and Bcl-X-L promote the persistence of CD8 T cells to recall tumor-associated antigen. J. Immunol. 175 (2005) 3534-3541
11. Salek-Ardakani S., Halteman B.S., Akiba H., Yagita H., and Croft M. OX40 (CD134) costimulation controls the response of memory T cells. FASEB J. 17 (2003) C214
12. Rogers P.R., Song J.X., Gramaglia I., Killeen N., and Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15 (2001) 445-455
13. Song J.X., and Croft M. OX40 (CD134) signals inhibit CD4 T cell apoptosis through multiple effects on the Bcl-2 family of proteins. FASEB J. 16 (2002) A313
14. Song J.X., Cheng M., Tang X.H., Altieri D.C., and Croft M. OX40 signals regulate Survivin expression and enhance CD4 T cell expansion. FASEB J. 18 (2004) A810
15. Sung J., Rogers P.R., Jember A., and Croft M. OX40 upregulates bcl-XL and bcl-2 and promotes survival of CD4 T cells. FASEB J. 15 (2001) A344
16. Salek-Ardakani S., Song S.X., Halteman B.S., Jember A.G.H., Akiba H., Yagita H., and Croft M. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J. Exp. Med. 198 (2003) 315-324
17. Gaspal F.M.C., Kim M.Y., McConnell F.M., Raykundalia C., Bekiaris V., and Lane P.J.L. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory. J. Immunol. 174 (2005) 3891-3896
18. Linton P.J., Bautista B., Biederman E., Bradley E.S., Harbertson J., Kondrack R.M., Padrick R.C., and Bradley L.M. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J. Exp. Med. 197 (2003) 875-883
19. Gramaglia I., Jember A., Pippig S.D., Weinberg A.D., Killeen N., and Croft M. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165 (2000) 3043-3050
20. Kato H., Kojima H., Ishii N., Hase H., Imai Y., Fujibayashi T., Sugamura K., and Kobata T. Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations. J. Clin. Immunol. 24 (2004) 237-248
21. Hendriks J., Xiao Y.L., Rossen J.W.A., van der Sluijs K.F., Sugamura K., Ishii N., and Borst J. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8(+) memory T cells and their capacity for secondary expansion. J. Immunol. 175 (2005) 1665-1676
22. Rogers P.R., and Croft M. Both Ox40 and CD28 are required for long-term Th1/Th2 effector development and T cell survival. FASEB J. 14 (2000) A985
23. Salek-Ardakani S., and Croft M. Regulation of CD4 T cell memory by OX40 (CD134). Vaccine 24 (2006) 872-883
24. Song J., Salek-Ardakani S., Rogers P.R., Cheng M., Van Parijs L., and Croft M. Sustained Akt activation mediated by OX40 controls long-term antigen driven CD4 T cell survival. FASEB J. 17 (2003) C227
25. Stuber E., Neurath M., Calderhead D., Fell H.F., and Strober W. Cross-linking of Ox40 ligand, a member of the Tnf/Ngf cytokine family, induces proliferation and differentiation in murine splenic B-cells. Immunity 2 (1995) 507-521
26. Stuber E., Neurath M., Calderhead D., Fell P., and Strober W. The Ox40-Ox40l interaction - a novel pathway in T-cell-dependent B-cell activation. FASEB J. 9 (3-10-1995) A771
27. Shaffer U.G., Kashork C.D., Saleki R., Rorem E., Sundin K., Ballif B.C., and Bejani B.A. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive-clinical cases. J. Pediatr. 149 (2006) 98-102
28. Pinkel D., Straume T., and Gray J.W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 2934-2938
29. Suhoski M.M., Golovina T.N., Aqui N.A., Tai V.C., Varela-Rohena A., Milone M.C., Carroll R.G., Riley J.L., and June C.H. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol. Ther. (3-20-2007)
30. Thomas A.K., Maus M.V., Shalaby W.S., June C.H., and Riley J.L. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. Clin. Immunol. 105 (2002) 259-272
31. Maus M.V., Thomas A.K., Leonard D.G.B., Allman D., Addya K., Schlienger K., Riley J.L., and June C.H. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol. 20 (2002) 143-148
32. Collette Y., Gilles A., Pontarotti P., and Olive D. A co-evolution perspective of the TNFSF and TNFRSF families in the immune system. Trends Immunol. 24 (2003) 387-394
33. Zhang H., Snyder K.M., Suhoski M.M., Maus M.V., Kapoor V., June C.H., and Mackall C.L. 4-1BB is superior to CD28 costimulation for generating CD8 cytotoxic lymphocytes for adoptive immunotherapy. J. Immunol. 179 (10-1-2007) 4910-4918
34. Lee S.W., Vella A.T., Kwon B.S., and Croft M. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol. 174 (6-1-2005) 6803-6808
35. Schmid I., Krall W.J., Uittenbogaart C.H., Braun J., and Giorgi J.V. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13 (1992) 204-208
36. Humphreys I.R., Schneider K., Benedict C., Munks M., Hill A., Ware C., and Croft M. OX40 mediates CD8 T cell responses to persistent murine cytomegalovirus (MCMV) infection. FASEB J. 19 (2005) A397
37. Weinberg A.D., Vella A.T., and Croft M. OX-40: life beyond the effector T cell stage. Semin. Immunol. 10 (1998) 471-480
38. Lee S.W., Park Y., Cheroutre H., Kwon B.S., and Croft M. Functional dichotomy between OX40 and 4-IBB in modulating effector CD8 T cell responses. J. Immunol. 176 (2006) S182
39. Huddleston C.A., Weinberg A.D., and Parker D.C. OX40 (CD134) engagement drives differentiation of CD4(+) T cells to effector cells. Eur. J. Immunol. 36 (2006) 1093-1103
40. Florido M., Borges M., Yagita H., and Appelberg R. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J. Leukoc. Biol. 76 (2004) 1039-1046
41. Agostini M., Cenci E., Pericolini E., Nocentini G., Bistoni G., Vecchiarelli A., and Riccardi C. The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection. Infect. Immun. 73 (2005) 7502-7508
42. Ballif B.C., Yu W., Shaw C.A., Kashork C.D., and Shaffer L.G. Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions. Hum. Mol. Genet. 12 (2003) 2153-2165